
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Increased atherogenic lipoprotein profile in children with non‐alcoholic steatohepatitis
Eduardo Castillo‐Leon, Margery A. Connelly, Juna V. Konomi, et al.
Pediatric Obesity (2020) Vol. 15, Iss. 9
Closed Access | Times Cited: 10
Eduardo Castillo‐Leon, Margery A. Connelly, Juna V. Konomi, et al.
Pediatric Obesity (2020) Vol. 15, Iss. 9
Closed Access | Times Cited: 10
Showing 10 citing articles:
Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases
Jorge Gutiérrez‐Cuevas, Arturo Santos, Juan Armendáriz‐Borunda
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11629-11629
Open Access | Times Cited: 145
Jorge Gutiérrez‐Cuevas, Arturo Santos, Juan Armendáriz‐Borunda
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11629-11629
Open Access | Times Cited: 145
Obesity and dyslipidemia in early life: Impact on cardiometabolic risk
Aleksandra Zeljković, Jelena Vekić, Aleksandra Stefanovic
Metabolism (2024) Vol. 156, pp. 155919-155919
Closed Access | Times Cited: 17
Aleksandra Zeljković, Jelena Vekić, Aleksandra Stefanovic
Metabolism (2024) Vol. 156, pp. 155919-155919
Closed Access | Times Cited: 17
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
Giovanni Targher, Kathleen E. Corey, Christopher D. Byrne
Diabetes & Metabolism (2020) Vol. 47, Iss. 2, pp. 101215-101215
Open Access | Times Cited: 131
Giovanni Targher, Kathleen E. Corey, Christopher D. Byrne
Diabetes & Metabolism (2020) Vol. 47, Iss. 2, pp. 101215-101215
Open Access | Times Cited: 131
Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
Jorge Gutiérrez‐Cuevas, Silvia Lucano‐Landeros, Daniel López-Cifuentes, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 23-23
Open Access | Times Cited: 39
Jorge Gutiérrez‐Cuevas, Silvia Lucano‐Landeros, Daniel López-Cifuentes, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 23-23
Open Access | Times Cited: 39
Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis
Constanze Hoebinger, Dragana Rajcic, Tim Hendrikx
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 22
Constanze Hoebinger, Dragana Rajcic, Tim Hendrikx
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 22
Shared genetic architecture between metabolic dysfunction-associated steatotic liver disease and cardiometabolic traits comorbidities: a genome-wide pleiotropic and multi-omics study
Xuan-Yu Wang, Qiong Lyu, Yangyang Zhang, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 2
Open Access
Xuan-Yu Wang, Qiong Lyu, Yangyang Zhang, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 2
Open Access
Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases
Siarhei A. Dabravolski, Evgeny E. Bezsonov, Mirza S. Baig, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6949-6949
Open Access | Times Cited: 24
Siarhei A. Dabravolski, Evgeny E. Bezsonov, Mirza S. Baig, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6949-6949
Open Access | Times Cited: 24
High-density lipoproteins and non-alcoholic fatty liver disease
Menno Hoekstra, Miranda Van Eck
Atherosclerosis Plus (2023) Vol. 53, pp. 33-41
Open Access | Times Cited: 10
Menno Hoekstra, Miranda Van Eck
Atherosclerosis Plus (2023) Vol. 53, pp. 33-41
Open Access | Times Cited: 10
Non-alcoholic fatty liver and fibrosis is associated with cardiovascular structure and function in young adults
Rosalind Tang, Kushala Abeysekera, Laura D. Howe, et al.
Hepatology Communications (2023) Vol. 7, Iss. 4
Open Access | Times Cited: 7
Rosalind Tang, Kushala Abeysekera, Laura D. Howe, et al.
Hepatology Communications (2023) Vol. 7, Iss. 4
Open Access | Times Cited: 7
Diabetes Mellitus Increases the Risk of Significant Hepatic Fibrosis in Patients With Non-alcoholic Fatty Liver Disease
Sandeep Chhabra, Sukhraj Singh, Arshdeep Singh, et al.
Journal of Clinical and Experimental Hepatology (2021) Vol. 12, Iss. 2, pp. 409-416
Open Access | Times Cited: 5
Sandeep Chhabra, Sukhraj Singh, Arshdeep Singh, et al.
Journal of Clinical and Experimental Hepatology (2021) Vol. 12, Iss. 2, pp. 409-416
Open Access | Times Cited: 5
Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
Anusha Vittal, Mark Shapses, Bashar Sharma, et al.
Hepatology Communications (2020) Vol. 5, Iss. 4, pp. 589-597
Open Access | Times Cited: 3
Anusha Vittal, Mark Shapses, Bashar Sharma, et al.
Hepatology Communications (2020) Vol. 5, Iss. 4, pp. 589-597
Open Access | Times Cited: 3